We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDYN icon
2276
Grid Dynamics Holdings
GDYN
$514M
$185K ﹤0.01%
+13,240
New +$171K
PARR icon
2277
Par Pacific Holdings
PARR
$3.94B
$183K ﹤0.01%
10,418
-28,018
-73% -$626K
FRSH icon
2278
Freshworks
FRSH
$2.99B
$182K ﹤0.01%
15,816
-121,284
-88% -$1.45M
IVCBW
2279
CALL
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$181K ﹤0.01%
15,329
-4,671
-23% -$173
CELC icon
2280
Celcuity
CELC
$4.01B
$177K ﹤0.01%
11,877
-140,414
-92% -$2.31M
EVRI
2281
DELISTED
Everi Holdings
EVRI
$175K ﹤0.01%
13,300
-414,621
-97% -$4.89M
KALV
2282
DELISTED
KalVista Pharmaceuticals
KALV
$173K ﹤0.01%
14,906
-34,005
-70% -$428K
BANC icon
2283
Banc of California
BANC
$3.21B
$171K ﹤0.01%
11,600
-1,400
-11% -$19.4K
CRVO icon
2284
CervoMed
CRVO
$24.6M
$170K ﹤0.01%
+11,657
New +$181K
LX
2285
LexinFintech Holdings
LX
$241M
$170K ﹤0.01%
62,500
-178,249
-74% -$311K
GSM icon
2286
FerroAtlántica
GSM
$617M
$168K ﹤0.01%
36,200
+9,249
+34% +$44.8K
AMZN icon
2287
PUT
Amazon
AMZN
$2.49T
$168K ﹤0.01%
900
-17,500
-95% -$3.19M
RLMD icon
2288
Relmada Therapeutics
RLMD
$546M
$164K ﹤0.01%
50,570
-106,049
-68% -$343K
ARQ icon
2289
Arq
ARQ
$85.4M
$163K ﹤0.01%
+27,700
New +$169K
CTV.WS
2290
CALL
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$162K ﹤0.01%
90,000
ECVT icon
2291
Ecovyst
ECVT
$1.34B
$161K ﹤0.01%
23,500
-123,886
-84% -$944K
BLUE
2292
DELISTED
bluebird bio
BLUE
$161K ﹤0.01%
+15,433
New +$257K
HSHP
2293
Himalaya Shipping
HSHP
$729M
$160K ﹤0.01%
+18,425
New +$146K
KYTX icon
2294
Kyverna Therapeutics
KYTX
$481M
$158K ﹤0.01%
32,223
+21,823
+210% +$168K
CDE icon
2295
Coeur Mining
CDE
$15.8B
$157K ﹤0.01%
+22,799
New +$142K
CAT icon
2296
CALL
Caterpillar
CAT
$402B
$156K ﹤0.01%
400
-100
-20% -$34.5K
CCRN
2297
DELISTED
Cross Country Healthcare
CCRN
$154K ﹤0.01%
+11,480
New +$169K
PLG
2298
Platinum Group Metals
PLG
$162M
$150K ﹤0.01%
+104,757
New +$153K
FSM icon
2299
Fortuna Silver Mines
FSM
$2.59B
$148K ﹤0.01%
+31,913
New +$151K
VIAV icon
2300
Viavi Solutions
VIAV
$9.41B
$147K ﹤0.01%
16,333
-3,267
-17% -$25.9K

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.